
Babu Uttam Kumar Rao Julapalli
About Babu Uttam Kumar Rao Julapalli
Data last updated:
Babu Uttam Kumar Rao Julapalli is a Director at Curewin-Hylico Pharma Private Limited (since 2015) and Director at Tablicaps Pharma Private Limited (since 2023). The companies operate in Pharma. The largest current company by reported revenue is Curewin-Hylico Pharma Private Limited at ₹9.02 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 12 Apr 2015 | 2014 | ₹9.02 Cr (FY 2025) | Active | |
| Director | 09 Jan 2023 | 2023 | Active |
Board colleagues of Babu Uttam Kumar Rao Julapalli
| Name | DIN | Company | Designation |
|---|---|---|---|
| Madhavaram Ravinder Rao | 08107645 | Curewin-Hylico Pharma Private Limited | Director |
| Srinivas Lagisetty | 06670295 | Curewin-Hylico Pharma Private Limited | Director |
| Parija Rangnekar | 07978234 | Tablicaps Pharma Private Limited | Director |
| Sudha Asthana | 09856053 | Tablicaps Pharma Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Babu Uttam Kumar Rao Julapalli
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Babu Uttam Kumar Rao Julapalli
Babu Uttam Kumar Rao Julapalli currently holds 2 directorships: Curewin-Hylico Pharma Private Limited (Director, since 12 Apr 2015, revenue ₹9.02 Cr (FY 2025)); Tablicaps Pharma Private Limited (Director, since 09 Jan 2023).
Babu Uttam Kumar Rao Julapalli was first appointed on 12 Apr 2015 as Director at Curewin-Hylico Pharma Private Limited. The most recent appointment on record is 09 Jan 2023 at Tablicaps Pharma Private Limited.
The current boards of Babu Uttam Kumar Rao Julapalli's companies include Madhavaram Ravinder Rao (Curewin-Hylico Pharma Private Limited), Srinivas Lagisetty (Curewin-Hylico Pharma Private Limited), Parija Rangnekar (Tablicaps Pharma Private Limited), Sudha Asthana (Tablicaps Pharma Private Limited).